Last reviewed · How we verify
NCT06699264: BFR
Effects of Low-intensity Strength Training With Concomitant Blood Flow Restriction on Pain Perception in Patients With Anterior Cruciate Ligament Surgery
NA trial testing Blood Flow Restriction Training in Anterior Cruciate Ligament Injury in 30 participants. Completed in 21 December 2024.
21 December 2024
Quick facts
| Lead sponsor | Praxisklinik Rennbahn AG |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 1 March 2023 |
| Primary completion | 21 December 2024 |
| Estimated completion | 21 December 2024 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Blood Flow Restriction Training
- Training without BFR
Conditions studied
- Anterior Cruciate Ligament Injury — all drugs for Anterior Cruciate Ligament Injury →
Sponsor
Praxisklinik Rennbahn AG
Who can join
Adults 18 to 60, any sex, with Anterior Cruciate Ligament Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
After surgical treatment of a tear of the anterior cruciate ligament, physiotherapeutic exercises are done as standard therapy. This is to achieve a rapid improvement in pain and knee function. In this study, the Investigators examine how low-intensity strength training with simultaneous restriction of blood flow works and whether it is effective and well tolerated. For this purpose, a pressure cuff is applied to the leg during training. Participation in this study will last four weeks for each participant. The Investigators will invite participants for 11 study visits. One appointment will last about 30 minutes. If a participant decides to take part in the study, they will be randomly assigned to one of two groups. The participants will belong to either an experimental group or the control group. In the experimental group, the participants will be treated with the intervention method. The intervention method involves 4 weeks of low-intensity strength training with an additional pressure cuff on the leg, which should lead to improved adaptations to the muscle as well as a reduction in pain. In the control group, the participants will receive the same strength training only without the additional pressure cuff. The benefit is that in addition to the participants actual rehabilitation program, each participant will receive free training to build their muscles. This could contribute to an accelerated rehabilitation process and a faster build-up of strength as well as an improvement in pain. It is additionally possible that the participants will help future patients with their participation. The intervention method for strength training with simultaneous restriction of blood flow (Blood Flow Restriction Training) has been studied for some time. There is good evidence of improved muscle, tendon and pain adaptations in both healthy individuals and patients with ACL injury. Whether this training method also has an effect on pain perception will be investigated in this study. Participants may experience side effects if they are treated with the intervention method (low-intensity strength training with simultaneous restriction of blood flow). The Investigators may not yet know all the risks and side effects of the intervention method. So far, the following risks and side effects are known: * Temporay numbness * Muscle soreness * Pressure sensation
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effect of blood flow restriction training in early postoperative rehabilitation after ACL reconstruction: a randomised controlled trial.
Barzyk P, Fiedler C, Schlag M, Heitner A, et al · · 2025 · PMID 41613017 · DOI 10.3389/fspor.2025.1689257
Verify or expand the search:
- PubMed search for NCT06699264
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Blood Flow Restriction Training
Trials testing the same drug.
- NCT07340385 — Physiological and Biochemical Responses to Blood Flow Restriction Training · recruiting
- NCT07140796 — Effects of Hip Blood Flow Restriction and Shockwave Therapy on Q-Angle and Plantar Pressure in Adults With Genu Varum · NA · not yet recruiting
- NCT06490692 — The Effect of Blood Flow Restriction Training on Tennis Elbow · NA · recruiting
- NCT06536777 — Effects of Ballistic Six Exercises With and Without Blood Flow Restriction in Cricket Players · NA · recruiting
- NCT06928181 — Effects of Passive Blood-Flow-Restriction on Muscle Atrophy and Pain After Elective Total Knee Arthroplasty · NA · completed
Other recruiting trials for Anterior Cruciate Ligament Injury
Currently open trials in the same condition.
- NCT06357091 — ACL Reconstruction With Shark Screw® or Biocomposite-interference Screws · NA · recruiting
- NCT05527171 — Virtual Reality Mindfulness Meditation After ACL Reconstruction · NA · recruiting
- NCT03935750 — STABILITY 2: Anterior Cruciate Ligament Reconstruction +/- Lateral Tenodesis With Patellar vs Quad Tendon · NA · active not recruiting
- NCT03348995 — The BEAR III Trial for Bridge-Enhanced ACL (Anterior Cruciate Ligament) Restoration · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06699264 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Praxisklinik Rennbahn AG
- Last refreshed: 17 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06699264.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing